High-frequency Contactless Sensor for the Detection of Heparin-Induced Thrombocytopenia Antibodies via Platelet Aggregation

Int J Mol Sci. 2022 Nov 19;23(22):14395. doi: 10.3390/ijms232214395.

Abstract

Heparin-induced thrombocytopenia (HIT), a severe autoimmune disorder, occurs in patients undergoing heparin therapy. The presence of platelet-activating antibodies against platelet factor 4/Heparin in the blood confirms patients suffering from HIT. The most widely used methods for HIT diagnosis are immunoassays but the results only suit to rule out HIT as the assays provide only around 50% specificity. To confirm HIT, samples with positive results in immunoassays are retested in functional assays (>98% specificity) that track platelet-activating antibodies via platelet aggregation. However, the protocols in functional assays are either time-consuming (due to the requirement of the detection of serotonin release) or require highly trained staff for the visualization of platelets. Here, we applied a cheap and easy-to-use contactless sensor, which employs high-frequency microwaves to detect the changes in the resonant frequency caused by platelet aggregation/activation. Analysis of change in conductivity and permittivity allowed us to distinguish between HIT-like (KKO) and non-HIT-like (RTO) antibodies. KKO caused a stronger reduction of conductivity of platelet samples than RTO. Our results imply that the high-frequency contactless sensor can be a promising approach for the development of a better and easier method for the detection of HIT.

Keywords: HIT; KKO/RTO antibody; conductivity; microwave contactless sensor; platelet aggregation/activation; reflection coefficient; resonant frequency.

MeSH terms

  • Antibodies
  • Heparin / adverse effects
  • Humans
  • Platelet Aggregation*
  • Platelet Factor 4
  • Platelet Function Tests
  • Thrombocytopenia* / chemically induced
  • Thrombocytopenia* / diagnosis

Substances

  • Platelet Factor 4
  • Heparin
  • Antibodies